Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zopiclone use during pregnancy.

O Diav-Citrin1, B Okotore, K Lucarelli

  • 1Hospital for Sick Children, Toronto.

Canadian Family Physician Medecin De Famille Canadien
|February 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal change in the treatment of nausea and vomiting of pregnancy in Ontario.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique·2000
Same author

Preconception counseling and women's compliance with folic acid supplementation.

Canadian family physician Medecin de famille canadien·1999
Same author

Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.

American journal of perinatology·1999
Same author

Pregnancy outcome following first trimester exposure to sumatriptan.

Neurology·1998
Same author

Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis.

Reproductive toxicology (Elmsford, N.Y.)·1998
Same author

Pregnancy outcome following maternal organic solvent exposure: a meta-analysis of epidemiologic studies.

American journal of industrial medicine·1998

Zopiclone, a medication for insomnia, does not appear to be a major human teratogen based on limited evidence. This information can help guide patient counseling regarding conception during zopiclone use.

Area of Science:

  • Pharmacology
  • Teratology
  • Obstetrics

Background:

  • Insomnia is a common condition often treated with medications like zopiclone.
  • Patient concerns arise regarding medication safety during pregnancy, particularly with conception during treatment.

Purpose of the Study:

  • To address clinical questions regarding the safety of zopiclone use during early pregnancy.
  • To provide guidance for healthcare providers counseling pregnant patients exposed to zopiclone.

Main Methods:

  • Review of available scientific literature and case reports on zopiclone exposure during pregnancy.
  • Assessment of teratogenic potential based on existing data.

Main Results:

  • Limited evidence suggests zopiclone is not a significant human teratogen.

Related Experiment Videos

  • No major birth defects definitively linked to zopiclone exposure in available studies.

    • Conclusions:

    • Zopiclone is unlikely to pose a major teratogenic risk to human fetuses.
    • Healthcare providers can reassure patients about the low risk of major birth defects with zopiclone exposure.